Lexeo Therapeutics Enters Into Agreement To Acquire Mantle Therapeutics And Announces Multiple New Strategic Collaborations To Expand Leadership In Friedreich Ataxia
LXEO•Agreement to acquire Mantle Therapeutics
Sept. 22 (Reuters) - Lexeo Therapeutics, Inc. LXEO.O:
- Lexeo Therapeutics enters into agreement to acquire Mantle Therapeutics and announces multiple new strategic collaborations to expand leadership in Friedreich ataxia
- Lexeo Therapeutics to pay $8.30 million upfront to Mantle shareholders
- Deal includes up to $13 million in milestone payments, for total potential consideration of $21.30 million
- Lexeo Therapeutics maintains cash runway guidance into 2028
